Supported By: Actelion, A Janssen Pharmaceutical Company of Johnson and Johnson; Merck & Co., Inc.; United Therapeutics, a public benefit company
Room: 157
Boston Convention and Exhibition Center

---

Program Description

Pulmonary arterial hypertension (PAH) is a chronic and life-changing progressive disease that, when left untreated, can lead to heart failure and death. Despite treatment advances and an increase in survival by more than 2-fold during the last 2 decades, PAH remains a fatal disease.

When should you suspect PH in your patients? How would you go about accurately diagnosing PAH? What treatment options are there once you establish a diagnosis? How often should you be following up with your patients, and why?

Join our panel of leading experts for an interactive symposium as they walk us through virtual simulations of patients with PAH, and participate in the clinical decision-making process as the cases evolve.

For more information and to register, please visit: www.medscape.org/symposium/pah-simulation

Target Audience

This activity is intended for pulmonologists, cardiologists, primary care physicians, nurses and nurse practitioners, physician assistants, and other clinicians who treat patients with pulmonary arterial hypertension.

Goal Statement

The goal of this activity is for learners to be better able to diagnose and treat pulmonary hypertension (PH) according to the latest evidence-based recommendations to help patients achieve low-risk status and optimize outcomes.

Learning Objectives

Upon completion of this activity, participants will:

Demonstrate improved performance associated with

• Patient evaluation to diagnose the correct PH subtype
• Risk assessment to determine patient risk and guide therapeutic decisions
• Selection of appropriate evidence-based treatment based on risk status across the spectrum of disease
• Ordering effective patient education and counseling for affected patients

For more information and to register, please visit: www.medscape.org/symposium/pah-simulation

Speaker

Moderator: Vallerie McLaughlin, MD
University of Michigan
Endowed Professor of Cardiovascular Medicine
Ann Arbor, MI

Presenter: Murali Chakinala, MD
Washington University School of Medicine
Professor of Medicine
St. Louis, MO

Presenter: Josanna Rodrigues-Lopez, MD
Harvard Medical School
Assistant Professor
Boston, MA